+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase mediated degradation of extracellular matrix in vitro correlates with formation of lung metastasis in nude mice



Urokinase mediated degradation of extracellular matrix in vitro correlates with formation of lung metastasis in nude mice



Fibrinolysis 4(Suppl. 3): 82




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144146

Download citation: RISBibTeXText


Related references

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Journal of Cell Biology 115(1): 191-199, 1991

Adhesion of prostate carcinoma cells to extracellular matrix in vitro correlates with the growth of the tumors in nude mice. Journal of Cell Biology 115(3 Part 2): 441A, 1991

U-PA production and u-PA mediated extracellular matrix degradation by rat prostate cancer cells in vitro correlates with metastatic behaviour in vivo. Fibrinolysis 8(Suppl. 1): 57, 1994

Urokinase-mediated extracellular matrix degradation in human prostate carcinoma and its inhibition by retinoic acid. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 282, 1994

Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clinical Cancer Research 1(7): 755-761, 1995

Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. Journal of Bone and Mineral Research 10(9): 1374-1384, 1995

Urokinase-type plasminogen activator and its receptor in extracellular matrix degradation by melanoma cell lines in vitro. Fibrinolysis 8(Suppl. 1): 93, 1994

Autocrine-generated matrix metalloproteinases of tumor cells and the cascade network of protease activation mediated by membrane associated urokinase-type plasminogen activator: involvement in the degradation of extracellular matrices. Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 104: 159-169, 1997

Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells. Microscopy Research and Technique 69(2): 73-83, 2006

Expression of cathepsin B, urokinase and urokinase receptor in colon tumor cells and stromal cells modulates extracellular matrix degradation. Molecular Biology of the Cell 13(Suppl.): 487a, 2002

Human T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro. Clinical and Experimental Immunology 151(2): 317-325, 2007

Novel experimental models of human cancer metastasis in nude mice lung metastasis intraabdominal carcinomatosis with ascites and liver metastasis. Journal of Cancer Research & Clinical Oncology 113(6): 544-549, 1987

Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice. European Journal of Medicinal Chemistry 56: 361-367, 2013

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Research 43(6): 2704-2711, 1983

Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1. Proceedings of the National Academy of Sciences of the United States of America 94(7): 2933-2938, 1997